A detailed history of Raymond James & Associates transactions in Stevanato Group S.P.A. stock. As of the latest transaction made, Raymond James & Associates holds 281,455 shares of STVN stock, worth $5.29 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
281,455
Previous 231,075 21.8%
Holding current value
$5.29 Million
Previous $4.24 Million 32.85%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

BUY
$17.98 - $22.02 $905,832 - $1.11 Million
50,380 Added 21.8%
281,455 $5.63 Million
Q2 2024

Jul 19, 2024

SELL
$16.93 - $31.33 $661,268 - $1.22 Million
-39,059 Reduced 14.46%
231,075 $4.24 Million
Q1 2024

Apr 22, 2024

BUY
$25.34 - $34.28 $1.64 Million - $2.22 Million
64,730 Added 31.51%
270,134 $8.67 Million
Q4 2023

Jan 16, 2024

BUY
$25.21 - $34.66 $203,898 - $280,330
8,088 Added 4.1%
205,404 $5.61 Million
Q3 2023

Oct 24, 2023

BUY
$26.91 - $35.49 $48,599 - $64,094
1,806 Added 0.92%
197,316 $5.86 Million
Q2 2023

Jul 25, 2023

BUY
$25.15 - $32.86 $32,393 - $42,323
1,288 Added 0.66%
195,510 $6.33 Million
Q1 2023

Apr 14, 2023

BUY
$17.5 - $25.9 $17,290 - $25,589
988 Added 0.51%
194,222 $5.03 Million
Q4 2022

Feb 08, 2023

SELL
$13.95 - $19.28 $139,402 - $192,665
-9,993 Reduced 4.92%
193,234 $3.47 Million
Q3 2022

Oct 25, 2022

BUY
$14.66 - $18.3 $851,599 - $1.06 Million
58,090 Added 40.02%
203,227 $3.44 Million
Q2 2022

Aug 12, 2022

BUY
$14.1 - $20.26 $1.01 Million - $1.45 Million
71,694 Added 97.62%
145,137 $2.3 Million
Q1 2022

May 11, 2022

SELL
$15.23 - $21.47 $77,977 - $109,926
-5,120 Reduced 6.52%
73,443 $1.48 Million
Q4 2021

Feb 08, 2022

BUY
$21.65 - $27.0 $6,343 - $7,911
293 Added 0.37%
78,563 $1.76 Million
Q3 2021

Nov 02, 2021

BUY
$19.51 - $28.7 $1.53 Million - $2.25 Million
78,270 New
78,270 $1.98 Million

Others Institutions Holding STVN

About Stevanato Group S.p.A.


  • Ticker STVN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 264,700,000
  • Market Cap $4.98B
  • Description
  • Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for pharma and healthcare. Its principal products include containment solutions, drug delivery systems, medical devices, diagnostic, analytical services, visual inspection machines, assembling and packaging machine...
More about STVN
Track This Portfolio

Track Raymond James & Associates Portfolio

Follow Raymond James & Associates and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.